Joe and Rich said the following during the 10/29/19 cc regarding partnerships with big pharma -


Copied and pasted -

Joe said regarding Altucell

So, Generex and the technology in this space, ALTuCELL--Generex is very
excited by acquiring this company. In addition, we've already started talking
to Big Pharma and partnering--we're partnering, licensing, and co-developing
this technology. And we believe, in the very near future, this would be a huge
value driver of the stock price in Generex as we are getting ready to list on
NASDAQ and maintain a substantial price once we receive that listing

And Rich said this regarding Arizona clinics

My background has been in clinical research, and I've run CROs for 17 years.
We're going to set up a clinical research centers with our 65,000 patients out
there, and a number of them--a large percentage, of course, because it's an
endocrinology clinic--have diabetes. It serves as a great research population.
And it's not just for new drugs from us, it's other drugs from other
companies--Big Pharma is interested in partnering on that whole front of our
new model of managing diabetes from start to finish. And we're going to
have a multispecialty practice set up to manage the diabetic population.